当前位置:首页>产品中心>单抗/多抗>Anti-Human TP53 Polyclonal Antibody|抗人TP53多克隆抗体(靶标:人肿瘤蛋白p53)

Anti-Human TP53 Polyclonal Antibody|抗人TP53多克隆抗体(靶标:人肿瘤蛋白p53)

  • 货号:RB9THY039034
  • 价格:面议
  • 点击:829
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human
靶标Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53; TP53; P53
免疫原E. coli - derived recombinant Human TP53 (Glu2-Asp393).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号P04637
背景信息

Cellular tumor antigen p53 (TP53) is a ~43 kDa protein. Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence. Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Negatively regulates cell division by controlling expression of a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression.

1. Guo, A. et al. (2000) Nature cell biology 2, 730-6. PMID: 11025664
2. Bergamaschi, D. et al. (2003) Nature genetics 33, 162-7. PMID: 12524540
3. Louria-Hayon, I. et al. (2003) The Journal of biological chemistry 278, 33134-41. PMID: 12810724
4. An, W. et al. (2004) Cell 117, 735-48. PMID: 15186775
5. Ghosh, A. et al. (2004) Molecular and cellular biology 24, 7987-97. PMID: 15340061
6. Zhao, Y. et al. (2007) The Journal of biological chemistry 282, 11969-81. PMID: 17317671
7. Taira, N. et al. (2007) Molecular cell 25, 725-38. PMID: 17349958
8. Allton, K. et al. (2009) Proceedings of the National Academy of Sciences of the United States of America 106, 11612-6. PMID: 19556538
9. Huarte, M. et al. (2010) Cell 142, 409-19. PMID: 20673990
10. Wu, L. et al. (2011) The Journal of biological chemistry 286, 2236-44. PMID: 20959462
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Mouse C5 Recombinant Antibody|抗小鼠C5重组抗体(靶标:小鼠补体C5) 1180
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 1100
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 940
Anti-Human CD39/ENTPD1 Recombinant Antibody|抗人CD39/ENTPD1重组抗体(靶标:人外核苷酸三磷酸二磷酸水解酶1/CD39) 922
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 1326
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 918
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 1212
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 977
Anti-Human α4β7/ITGA4 & ITGB7 Recombinant Antibody |抗人α4β7/ITGA4和ITGB7重组抗体(靶标:人整合素α4β7复合物) 806
Anti-Human CD2BP2 Polyclonal Antibody|抗人CD2BP2多克隆抗体(靶标:人CD2结合蛋白2) 1138
InVivoMAb anti-Mouse IL-6R alpha&IL6R Antibody|InVivoMAb抗小鼠IL-6Rα和IL6R抗体(靶标:小鼠白细胞介素6受体) 1113
Anti-Human EGFR/ERBB1/HER1 Reference Antibody|抗人EGFR/ERBB1/HER1参照抗体(靶标:人表皮生长因子受体(研究用)) 994
Anti-Human CD279/PD-1 Recombinant Antibody|抗人CD279/PD-1重组抗体(靶标:人程序性细胞死亡蛋白1/PD-1) 1261
Anti-Human CD279/PD-1 Recombinant Antibody, FITC|抗人CD279/PD-1重组抗体, FITC标记(靶标:人程序性细胞死亡蛋白1/PD-1(FITC标记)) 1112
Anti-Human CD279/PD-1 Recombinant Antibody, PE|抗人CD279/PD-1重组抗体, PE标记(靶标:人程序性细胞死亡蛋白1/PD-1(PE标记)) 950
Anti-Human CD279/PD-1 Recombinant Antibody, APC|抗人CD279/PD-1重组抗体, APC标记(靶标:人程序性细胞死亡蛋白1/PD-1(APC标记)) 1196
Anti-Human CD279/PD-1 Recombinant Antibody, PerCP|抗人CD279/PD-1重组抗体, PerCP标记(靶标:人程序性细胞死亡蛋白1/PD-1(PerCP标记)) 1157
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 1017
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 880
Anti-Evolocumab Non-Neutralizing Recombinant Antibody |抗依洛尤单抗非中和重组抗体(靶标:依洛尤单抗非中和抗体) 1124
总计 33036 个记录,共 1652 页,当前第 1643 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30